Resona Asset Management Co. Ltd. Trims Stake in Henry Schein, Inc. $HSIC

Resona Asset Management Co. Ltd. trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 96.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,168 shares of the company's stock after selling 35,673 shares during the period. Resona Asset Management Co. Ltd.'s holdings in Henry Schein were worth $80,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Guggenheim Capital LLC boosted its position in Henry Schein by 2.5% during the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company's stock valued at $445,000 after buying an additional 159 shares during the period. UMB Bank n.a. boosted its holdings in shares of Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the period. Humankind Investments LLC boosted its holdings in shares of Henry Schein by 7.4% during the fourth quarter. Humankind Investments LLC now owns 3,057 shares of the company's stock worth $212,000 after purchasing an additional 211 shares during the period. HB Wealth Management LLC boosted its holdings in shares of Henry Schein by 1.5% during the first quarter. HB Wealth Management LLC now owns 15,419 shares of the company's stock worth $1,056,000 after purchasing an additional 226 shares during the period. Finally, J. Safra Sarasin Holding AG boosted its holdings in shares of Henry Schein by 1.1% during the fourth quarter. J. Safra Sarasin Holding AG now owns 22,098 shares of the company's stock worth $1,529,000 after purchasing an additional 231 shares during the period. 96.62% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on HSIC shares. Wells Fargo & Company dropped their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Piper Sandler dropped their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. JPMorgan Chase & Co. lowered their price objective on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. Robert W. Baird restated a "neutral" rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Finally, UBS Group lowered their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Four equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $75.58.

Henry Schein Stock Up 0.5%

NASDAQ HSIC traded up $0.33 during mid-day trading on Wednesday, reaching $68.64. The stock had a trading volume of 2,059,320 shares, compared to its average volume of 1,773,902. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The stock has a market cap of $8.32 billion, a PE ratio of 22.14, a price-to-earnings-growth ratio of 2.22 and a beta of 0.81. The company has a fifty day moving average price of $70.67 and a 200 day moving average price of $70.61. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period last year, the firm posted $1.23 EPS. The company's revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.